Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy

Abstract Background Interleukin-6 blockade (IL-6) has become a focus of therapeutic investigation for the coronavirus disease 2019 (COVID-19). Methods We report a case of a 34-year-old with COVID-19 pneumonia receiving an IL-6 receptor antagonist (IL-6Ra) who developed spontaneous colonic perforatio...

Full description

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases Vol. 7; no. 11; p. ofaa424
Main Authors: Schwab, Kristin, Hamidi, Sepehr, Chung, Augustine, Lim, Raymond J, Khanlou, Negar, Hoesterey, Daniel, Dumitras, Camelia, Adeyiga, Oladunni B, Phan-Tang, Michelle, Wang, Tisha S, Saggar, Rajan, Goldstein, Jeffrey, Belperio, John A, Dubinett, Steven M, Kim, Jocelyn T, Salehi-Rad, Ramin
Format: Journal Article
Language:English
Published: US Oxford University Press 01-11-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Interleukin-6 blockade (IL-6) has become a focus of therapeutic investigation for the coronavirus disease 2019 (COVID-19). Methods We report a case of a 34-year-old with COVID-19 pneumonia receiving an IL-6 receptor antagonist (IL-6Ra) who developed spontaneous colonic perforation. This perforation occurred despite a benign abdominal exam and in the absence of other known risk factors associated with colonic perforation. Results Examination of the colon by electron microscopy revealed numerous intact severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions abutting the microvilli of the colonic mucosa. Multiplex immunofluorescent staining revealed the presence of the SARS-CoV-2 spike protein on the brush borders of colonic enterocytes that expressed angiotensin-converting enzyme 2. However, no viral particles were observed within the enterocytes to suggest direct viral injury as the cause of colonic perforation. Conclusions These data and absence of known risk factors for spontaneous colonic perforation implicate IL-6Ra therapy as the potential mediator of colonic injury in this case. Furthermore, this report provides the first in situ visual evidence of the virus in the colon of a patient presenting with colonic perforation adding to growing evidence that intact infectious virus can be present in the stool.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
K. S., S. H., R. S.-R., and J. T. K. contributed equally to this manuscript.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofaa424